Mark E. Cooper

2.6k citations
18 papers · 2.2k · 1 hit paper · h-index 14

Impact in

Papers in

Mark E. Cooper

17 papers receiving 2k citations

Mark E. Cooper's Hit Papers

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study 2000 · 817 citations
8170+8+17Years since publication250500750

Peers

Mark E. Cooper
Comparison fields: 5 of 72
  • Nephrology 1.1k
  • Cardiology and Cardiovascular Medicine 820
  • Clinical Biochemistry 120
  • Endocrinology, Diabetes and Metabolism 124
  • Ophthalmology 52
Replace H.-H. Parving with:
H.-H. Parving Denmark
Alois Saller Italy
Per Knud Christensen Denmark
Michele Dalla Vestra Italy
Aneliya Ilieva Parvanova Italy
Ilian Petrov Iliev Italy
Carl Erik Mogensen Denmark
Cecilia Fondelli Italy
Bastian Dehmel United States
Toshinobu Sato Japan
Mark E. Cooper relative to H.-H. Parving Denmark H.-H. Parving's profile →
Citations per field
00.5×2×3.1×
H.-H. Parving · 1×
Citations per year

Countries citing papers authored by Mark E. Cooper

Since Specialization
Citations

This map shows the geographic impact of Mark E. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Cooper more than expected).

Fields of papers citing papers by Mark E. Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Cooper. The network helps show where Mark E. Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Cooper Line = papers co-authored together Mark E. Cooper links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
Hit paper breakdown →
2000817
2 2002428
3 2001220
4 1998189
5 200091
6 200679
7 200471
8 199954
9 199247
10 198845
11 200839
12 200537
13 200324
14 201318
15 19899
16 19975
17 20001
18
Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial
20081

About Mark E. Cooper

Mark E. Cooper is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Orthopedics and Sports Medicine and Hematology, having authored 18 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (11 papers), Blood Pressure and Hypertension Studies (3 papers), Renin-Angiotensin System Studies (3 papers), Bone health and osteoporosis research (2 papers), Advanced Glycation End Products research (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Erythropoietin and Anemia Treatment (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Nephrology (1.1k citations), Cardiology and Cardiovascular Medicine (820 citations), Clinical Biochemistry (120 citations), Endocrinology, Diabetes and Metabolism (124 citations) and Ophthalmology (52 citations). Mark E. Cooper has collaborated with scholars based in Australia, Denmark and Israel. Frequent co-authors include Dick de Zeeuw, Barry Morton Brenner, Ilkka Tikkanen, R J Viskoper, S Oren, Carl Erik Mogensen, Steen Neldam, Terri J. Allen, Fabrice Bonnet and Geoffrey Boner. Their work appears in journals such as Diabetologia, Journal of Hypertension, Diabetes & Metabolism, Current Eye Research and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact